Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Update: Online Hospital Registration Platform 91160 Wins RMB 130 Mln Series B

Sina Tech, 5/12/15

Shenzhen-based Ningyuan Technology, operator of online hospital registration platform 91160.com (Jiuyi 160), recently announced it has completed RMB 130 mln Series B funding from Costone Venture Capital and GX Capital.

Jiuyi 160's user base has grown from 10 mln at the end of 2014 to its current 19 mln, a 90% increase. Hospital registrations have increased 35% over the same period, going from 26 mln to 35 mln. Hospital coverage has expanded from 600 to 1,000, 70% growth from December 2014.

China's major tech companies all have deals with Ningyuan to provide Jiuyi 160 services to users. On May 5, the company signed a deal with Alibaba Health Information Technology (0241.HK), an affiliate of Alibaba Group (NYSE: BABA), to partner on online hospital appointments and health consultation services. In April, Chinese internet company Baidu (Nasdaq: BIDU) announced a deal where Jiuyi 160 will provide users of Baidu's "Baidu Doctor" ("Baidu Yishen") mobile healthcare app with hospital appointment booking services as Baidu attempts to develop an online healthcare business in top tier cities. Tencent's (0700.HK) WeChat mobile messaging app also connects to Jiuyi 160 to provide hospital booking services.

Editor's Note: For more information on this topic, please see "Online Hospital Registration Platform 911160 Lands RMB 9-digit Series B," MD 4/07/15 issue, and "Online Hospital Registration Platform 91160 Secures RMB 8-digit Series A," MD 1/31/14 issue.

Keywords: mobile healthcare Internet funding online healthcare Baidu Tencent 0700.HK BIDU Alibaba Group Alibaba Health 0241.HK BABA Costone GX Capital Jiuyi 160 VC second-round

Feedback

Please note, all fields are required.
None of your personal information will be shared with third parties.

SendingSending

Disclaimer

The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports